0
Letters to the Editor |

Estimation of Haplotypes at DRD2 May Have Produced Misleading Results

David Curtis, MD, PhD; Hugh Gurling, MD, MPhil, FRCPsych
[+] Author Affiliations

Copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

More Author Information
Arch Gen Psychiatry. 2006;63(8):939-939. doi:10.1001/archpsyc.63.8.939-a
Text Size: A A A
Published online

We are concerned that the results appearing to implicate an effect of DRD2 polymorphisms on the susceptibility to heroin dependence1 may represent statistical artifacts rather than a true genetic effect. To a very large extent, the results are based on estimating the frequencies of haplotypes in cases and controls and testing for a difference, the frequencies being estimated using the MLOCUS program.2 Likelihood ratio tests assuming a χ2 distribution were reported to produce P values as low as 10−10. A Fisher exact test for 1 haplotype produced a P value of 10−22.

In case-control studies, haplotypes are not observed directly and their frequencies are only estimated. The authors of the MLOCUS program wrote that the use of the χ2 distribution could lead to an inflated type I error rate and hence recommended using resampling methods to obtain statistical significance.2 Apparently minor errors in the estimation of haplotype frequency can yield very misleading results. For example, for a sample of a few hundred subjects, if a haplotype frequency is estimated at 0.01 rather than a true value of 0.003, then a likelihood ratio test value on the order of 100 can be generated. Treating such a statistic as χ2 will produce an infinitesimal, but incorrect, P value. Nor is it appropriate to apply the Fisher exact test to inferred frequencies rather than directly observed counts.

It seems to us that the results presented are inherently implausible. Taken at face value, they show that 3 haplotypes are present with a total frequency of almost 20% in heroin addicts but are not found at all in controls. This would imply that around a third of addicts would carry at least 1 copy of such a high-risk haplotype but that no controls would. It is hard to believe that a third of drug addicts carry some genetic risk factor that is not found in hundreds of controls—by implication a risk factor that would cause all who inherited it to go and become dependent on heroin. From the published information, it is difficult to see exactly what has gone wrong, but the inference of haplotypes is inherently a problematic endeavor and we strongly suspect that on this occasion the process may have produced misleading results.

AUTHOR INFORMATION

Correspondence: Dr Curtis, Department of Adult Psychiatry, Royal London Hospital, Whitechapel, London E1 1BB, United Kingdom (dave@davecurtis.net).

REFERENCES

Xu  K, Lichtermann  D, Lipsky  RH, Franke  P, Liu  X, Hu  Y, Cao  L, Schwab  SG, Wildenauer  DB, Bau  CH, Ferro  E, Astor  W, Finch  T, Terry  J, Taubman  J, Maier  W, Goldman  D. Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry 2004;61597- 606
PubMed
Long  JC, Williams  RC, Urbanek  M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 1995;56799- 810
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Xu  K, Lichtermann  D, Lipsky  RH, Franke  P, Liu  X, Hu  Y, Cao  L, Schwab  SG, Wildenauer  DB, Bau  CH, Ferro  E, Astor  W, Finch  T, Terry  J, Taubman  J, Maier  W, Goldman  D. Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry 2004;61597- 606
PubMed
Long  JC, Williams  RC, Urbanek  M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 1995;56799- 810
PubMed

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...